Yong Peng
Direttore/Membro del Consiglio presso Beijing Shenogen Pharma Group Ltd.
Posizioni attive di Yong Peng
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | 01/10/2019 | - |
| Corporate Officer/Principal | 01/07/2018 | - |
Storia della carriera di Yong Peng
Formazione di Yong Peng
| Peking University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Cina | 3 |
Posizioni
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Consumer Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Yong Peng
- Esperienza
